W

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy

Business Management
Share
Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy

The drugmaker, best known for developing weight-loss and diabetes drugs, failed to excite investors hoping for a turnaround.

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Bithumb discloses data leak after internal system breach: Report

The breach impacted its inhouse mobile system, used by employees for work and information sharing. Source：Cointelegraph

Discord is making public chats searchable on Google: How to opt out

Discord conversations on large public servers will soon reach audiences far beyond their communities, raising privacy concerns. Source：Cointelegraph

CoreWeave and other AI stocks rise as Anthropic restores the market’s faith in sustained spending

Now that investors have been able to dive further into Anthropic’s IPO filing, they’re seeing the same sorts of trends that helped buoy AI stocks for much of…

As Trump touts energy companies’ fortunes, U.S. consumers face the most expensive year for gas prices ever

President Donald Trump can’t stop touting the fortunes U.S. energy companies have made during the Iran war, while canvassing the country to support Republican…

Source：https://www.marketwatch.com/story/novo-nordisk-stock-tumbles-as-ozempic-maker-sets-out-2030-goals-8a5a8d2d